Stock Report

All about this stock under one free report Last Updated: 22-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Ajanta Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: AJANTPHARM | BSE: 532331

₹3,540.00

up-down-arrow ₹-2.10 (-0.06%)

As on 22-Sep-2026 11:59IST

Market cap

info icon

₹44,048 Cr

Revenue (TTM)

info icon

₹5,776 Cr

P/E Ratio

info icon

38.8

P/B Ratio

info icon

9.1

Div. Yield

info icon

0.8 %

Edit peer-selector-edit
Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Market cap (₹ Cr)
 44,048 1,16,843 97,363 97,066 1,01,293
Revenue (₹ Cr)
 5,776 28,592 34,935 29,967 33,228
Net Profit (₹ Cr)
 1,134.88 4,492.20 3,712.74 5,551.01 3,169.30
Net Margin (%)
 18.94 14.92 10.42 18.23 9.15
RoE (%)
 25.67 18.78 10.38 28.32 8.72
Price to Earnings
 38.81 25.89 26.23 17.56 31.44
Price-To-Book
 9.07 4.33 2.50 4.08 2.65

Income Statement (₹ Cr)

Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Operating Revenue arrow
5,776.17 28,591.70 34,935.29 29,966.58 33,227.90
Total Income arrow
5,992.81 30,111.40 35,624.79 30,442.31 34,650.70
Total Expenditure arrow
4,309.11 21,334.70 27,850.01 20,428.27 28,088.10
EBITDA arrow
1,467.06 7,257.00 7,085.28 9,538.31 5,139.80
Depreciation arrow
176.35 1,724.60 1,859.31 1,529.37 2,119.30
EBIT arrow
1,290.71 5,532.40 5,225.97 8,008.94 3,020.50
Interest arrow
14.03 510.20 387.88 452.37 416.30
Other Income arrow
216.64 1,519.70 689.50 475.73 1,422.80
Exceptional Items arrow
0.00 -534.80 -105.51 -557.91 0.00
Profit before Tax arrow
1,493.32 6,007.10 5,422.08 7,474.39 4,027.00
Provision for Tax arrow
358.44 1,514.90 1,709.34 1,923.38 857.70
Profit after Tax arrow
1,134.88 4,492.20 3,712.74 5,551.01 3,169.30

Liabilities (₹ Cr)

Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Shareholder's Funds arrow
4,527.09 27,111.40 37,890.97 22,448.27 37,891.50
Minority Interest arrow
0.00 -79.70 1.76 -22.18 38.90
Non-Current Liabilities arrow
212.00 7,112.50 2,580.33 3,200.22 3,145.10
Current Liabilities arrow
1,415.75 15,711.90 18,039.01 12,651.24 16,747.40
Total Liabilities arrow
6,317.22 50,672.60 58,196.15 38,146.06 56,576.70

Assets (₹ Cr)

Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Non-Current Assets arrow
2,243.07 31,677.20 24,040.45 11,888.82 27,204.00
Current Assets arrow
3,735.43 19,906.10 32,708.75 24,027.38 30,179.30
Total Assets arrow
6,317.22 50,672.60 58,196.15 38,146.06 56,576.70
Total Debt* arrow
211.99 11,769.50 7,676.20 5,910.20 7,734.10
Net Current Assets arrow
2,319.68 4,194.20 14,669.74 11,376.14 13,431.90
Contingent Liabilities arrow
8.12 989.90 1,358.37 1,094.02 336.14

Cashflow (₹ Cr)

Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Cash From Operating Activities arrow
529.19 2,116.60 5,526.37 7,334.50 5,673.70
Cash Flow from Investing Activities arrow
-428.92 -8,296.10 -3,458.61 -3,864.59 -6,549.30
Cash from Financing Activities arrow
-167.92 5,806.90 -1,269.15 -845.87 829.00
Net Cash Inflow / Outflow arrow
-67.65 -372.60 798.61 2,624.04 -46.60

Ratios

Profitability Ratios

 Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
ROCE (%) arrow
32.67 21.39 12.76 28.86 13.75
ROE (%) arrow
25.67 18.78 10.38 28.32 8.72
ROA (%) arrow
20.32 10.03 6.86 16.43 5.89
EBIT Margin (%) arrow
22.35 19.35 14.96 26.73 9.09
Net Margin (%) arrow
18.94 14.92 10.42 18.23 9.15
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Revenue Growth (%) arrow
20.19 21.11 9.09 28.19 -0.87
EBIT Growth (%) arrow
14.32 -8.99 6.91 77.03 -55.06
Net Profit Growth (%) arrow
22.04 -3.14 8.63 49.13 -44.66
EPS Growth (%) arrow
22.01 4.31 11.88 60.86 -43.29
Book Value Growth (%) arrow
19.52 13.19 16.04 30.75 12.99

Valuation Ratios

 Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Price / Earnings arrow
38.92 23.71 26.29 16.26 31.13
Price / Book Value arrow
9.09 4.30 2.54 4.07 2.63
Dividend Yield (%) arrow
0.79 0.09 0.23 0.85 0.67
EV/EBITDA arrow
29.80 16.60 13.53 9.82 19.66
Market Cap (₹ Cr) arrow
35,015.54 87,643.18 75,689.14 1,05,737.27 1,04,763.81

Solvency Ratios

 Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Debt to Equity arrow
0.00 0.12 0.02 0.07 0.00
Short term debt to equity ratio arrow
0.05 0.16 0.16 0.18 0.16
Current Ratio arrow
2.64 1.27 1.81 1.90 1.80
Quick Ratio arrow
1.98 0.91 1.15 1.42 1.35
Interest Coverage arrow
107.44 12.77 14.98 17.52 10.67

Operating Efficiency Ratios

 Ajanta Pharma Zydus Lifesciences Aurobindo Pharma Lupin Dr. Reddy'S Labs
Debtors to sales (%) arrow
32.10 18.94 20.31 22.04 30.47
Asset Turnover arrow
1.03 0.64 0.65 0.89 0.62
Receivable days arrow
49.07 33.55 33.71 51.23 103.79
Inventory Days arrow
29.77 33.80 59.32 48.93 79.94
Payable days arrow
183.00 149.82 148.20 205.75 84.78
Cash Conversion Cycle arrow
-104.16 -82.46 -55.17 -105.59 98.95
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...